CJC-1295 (No DAC) + Ipamorelin is a research-only peptide combination formulated for laboratory studies focused on growth hormone–related signaling pathways and peptide synergy. This blend is commonly used in controlled research settings to explore interactions between growth hormone–releasing hormone (GHRH) analogs and ghrelin mimetics.

The no-DAC version of CJC-1295 is designed for shorter-acting research applications, while Ipamorelin is studied for its selective receptor activity within growth hormone signaling pathways.

Key Research Components

CJC-1295 (No DAC) – A modified GHRH analog studied for its role in stimulating growth hormone signaling and downstream cellular pathways without drug affinity complex (DAC) binding.

Ipamorelin – A pentapeptide ghrelin mimetic researched for its selective interaction with growth hormone secretagogue receptors and signaling modulation.

Research Focus Areas

• Growth hormone signaling pathways

• Peptide-receptor interaction studies

• Endocrine and metabolic signaling research

• Advanced peptide synergy investigations

Quality & Specifications

• High-purity peptide blend (≥99%)

• Lyophilized for laboratory stability

• Independently tested for identity and purity

• Manufactured in controlled research-grade facilities

Important Notice

For Research Use Only.

This product is not intended for human or animal consumption, clinical use, or diagnostic purposes. Intended exclusively for qualified researchers conducting laboratory research.